An observational study in Shock, sponsored by Zoll Medical Corporation. Completed at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-07-24.
Sponsored by Zoll Medical Corporation · Observational
Evaluate the implementation of a standardized mobile resuscitation model to manage SWOT within a large acute care hospital setting.
Immediately upon identification of SWOT, the SWOT Team will be activated by clinicians to respond to the patient bedside. Clinicians on-site will initiate patient care as directed by hospital protocol. Upon arrival, the SWOT Team will take over the management of patient care. The team will include 1-2 intensivists and multiple clinicians with clearly defined roles, dependent upon clinical presentation. The mobile resuscitative platform equipped with critical care technology will be delivered to the bedside (refer to appendix for full equipment content).
The SWOT Team will implement goal-directed therapy using real-time monitoring and advanced diagnostic point-of-care tools. ultrasound, arterial and central lines will be placed by the intensivist(s) to monitor the physiology of the patient during treatment in real-time. Other team members (RNs, Respiratory Therapist's, residents, anesthesiologists, and technicians) will place the patient on continuous ECG and SPO2 monitoring, continuous capnographic monitoring via nasal canula or Endotracheal tube, and continuous cerebral and regional NIRS monitors. Point-of-care laboratory values will also be measured. Resuscitative interventions will be performed as directed by team leader to target the following physiological target parameters:
921 studies on the registry are indexed under Shock; 172 are open to participants now.
This study's enrollment of 27 is below the median of 93 across 355 observational studies indexed under Shock.
Browse Shock studies →Zoll Medical Corporation is the lead sponsor of 35 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients meeting all enrollment criteria will be eligible for enrollment in the study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Presence of shock, defined as systolic blood pressure (SBP) less than 90 mmHg with signs of hypoperfusion, including at least one of the following (without alternate causes):
Candidates for the prospective case series must meet the following inclusion criterion:
Exclusion Criteria:
Candidates for the prospective case series will be excluded if the following condition is present:
Patients experiencing shock without trauma once all training is in place and devices are deployed
Device: Full SWOT Model
Bundle of care that includes devices such as X Series monitor/defibrillator, AutoPusle automated compression device, Z Vent ventilator, and IPR therapies as well as bedside monitoring and diagnostics and training on a standardized care process.
Time to Shock Reversal
Duration in minutes from activation of the SWOT Team to shock reversal, defined as stable arterial pressure (SBP \> 90 mmHg) without requirement for vasopressor administration for greater than 24 hours and normalization of systemic and local perfusion measures of lab-measured lactate indicating improved systemic perfusion
Time frame: From 24 hours to 72 hours after initial shock event
30-day Mortality
Patient all-cause mortality will be assessed at 30 days following initial identification of shock symptoms
Time frame: 30 days after initial shock event
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.